Atrys Health, S.A.

MCE ATRY.MC

Atrys Health, S.A. Return on Equity (ROE) for the year ending December 31, 2023: -15.73%

Atrys Health, S.A. Return on Equity (ROE) is -15.73% for the year ending December 31, 2023, a -126.27% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.

Atrys Health, S.A. Return on Equity (ROE) for the year ending December 31, 2022 was -6.95%, a 17.89% change year over year.
Atrys Health, S.A. Return on Equity (ROE) for the year ending December 31, 2021 was -8.47%, a -216.43% change year over year.
Atrys Health, S.A. Return on Equity (ROE) for the year ending December 31, 2020 was -2.68%, a -920.03% change year over year.
Atrys Health, S.A. Return on Equity (ROE) for the year ending December 31, 2019 was -0.26%, a -678.64% change year over year.

Key data

Date	Return on Equity (ROE)	Return on Capital Employed (ROCE)	Interest Coverage Ratio	Debt to Equity Ratio

MCE: ATRY.MC

Atrys Health, S.A.

CEO	Ms. Isabel Lozano Fernandez
IPO Date	July 22, 2016
Location	Spain
Headquarters	Calle VelAzquez, 24
Employees	2,084
Sector	Healthcare
Industries Biotechnology Medical Instruments Pharmaceuticals Telehealth

Description

Atrys Health, S.A., a biomedical company, provides diagnostic services and medical treatments. The company offers diagnostic services in the fields of pathology, hematology, molecular pathology, and genetics; and diagnostic second opinion, test directory, and clinical trials and R&D services. It uses telemedicine to provide its services in the medical specialties of radiology, cardiology, ophthalmology, and dermatology. The company also provides radiotherapy; and develops therapeutic modalities and diagnostic tools. The company was formerly known as Althia Health, S.L. and changed its name to Atrys Health, S.A. in May 2016. Atrys Health, S.A. was incorporated in 2007 and is headquartered in Madrid, Spain.

Key trends

Past 5 years